Sexualized Drug Use and Chemsex among Men Who Have Sex with Men in Europe: A Systematic Review and Meta-Analysis
Journal of Clinical Medicine · 21.03.2024 · 13 (6) · 1812
DOI: 10.3390/jcm13061812 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 21.03.2024. Verfasst von Marina Coronado-Muñoz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Preventive Medicine and Public Health Department, Faculty of Medicine, University of Seville, Av. Sanchez Pizjuan s/n, 41009 Seville, Spain. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In recent years, in Europe, there has been a growing concern about the use of sexualized drugs among men who have sex with men (MSM), due to its possible link to an increase in sexually transmitted infections. The aim of this review is to study the prevalence of chemsex, and the sexualized drug used in Europe, describing both different consumption patterns and other sexual behaviors considered risky and their possible relationship with positivity in diagnoses of sexually transmitted infections, including human immunodeficiency virus.
Methods
We conducted a literature review in the main scientific databases (PubMed, Embase, Scopus, Cochrane Library, Web of Science), filtering for articles published between January 2018 and April 2023 that collect information on sexualized drug use and sexual practices conducted in European countries among men who have sex with men, including whether these behaviors can lead to diagnoses of sexually transmitted infections.
Results
The definition of drugs included in chemsex is not clearly defined and shows heterogeneity between study publications; the three drugs presented in all manuscripts are mephedrone, GHB/GBL, and crystal methamphetamine. The prevalence of chemsex in Europe is 16% [11–21%] among MSM. The most frequent risky sexual behavior associated with chemsex practice was unprotected sex with a high number of partners. The log risk ratio of STIs was 0.86 (95% CI: 0.49 to 1.23).
Conclusions
Adherence to definitions, stringent research methodologies, and focused interventions are needed to tackle the intricate relationship between substance use, sexual behavior, and the risk of HIV/STI transmission in MSM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Preventive Medicine and Public Health Department, Faculty of Medicine, University of Seville, Av. Sanchez Pizjuan s/n, 41009 Seville, Spain.
- Department of Preventive Medicine, Hospital Universitario de Valme, Ctra. de Cádiz Km. 548.9, 41014 Seville, Spain.
- Department of Preventive Medicine, Virgen Macarena University Hospital, Avda. Dr. Fedriani 3, 41009 Seville, Spain.
ORCID-Profile: Emilio García-Cabrera, Angélica Quintero-Flórez, Ángel Vilches-Arenas
Zitieren
APA
Coronado-Muñoz, M., García-Cabrera, E., Quintero-Flórez, A., Román, E., & Vilches-Arenas, Á. (2024). Sexualized Drug Use and Chemsex among Men Who Have Sex with Men in Europe: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 13(6), 1812. https://doi.org/10.3390/jcm13061812
Vancouver
Coronado-Muñoz M, García-Cabrera E, Quintero-Flórez A, Román E, Vilches-Arenas Á. Sexualized Drug Use and Chemsex among Men Who Have Sex with Men in Europe: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2024;13(6):1812. doi:10.3390/jcm13061812
BibTeX
@article{CoronadoMuoz2024,
author = {Coronado-Muñoz, Marina and García-Cabrera, Emilio and Quintero-Flórez, Angélica and Román, Encarnación and Vilches-Arenas, Ángel},
title = {Sexualized Drug Use and Chemsex among Men Who Have Sex with Men in Europe: A Systematic Review and Meta-Analysis},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {6},
pages = {1812},
doi = {10.3390/jcm13061812}
}
EUVIMED